Éñ¾ÍËÐÐÐÔ¼²²¡Ä£ÐÍ
Éñ¾ÍËÐÐÐÔ¼²²¡£¨Neurodegenerative Disease, NDD£©ÊÇÒ»Àà·¢ÉúÔÚÉñ¾ÏµÍ³ÖУ¬Ôì³ÉÉñ¾Ôª¼°ÆäÁ¥ÊôÊ÷Í»¡¢ÖáÍ»ºÍÍ»´¥£¬ÒÔ¼°±é²¼Éñ¾ÏµÍ³µÄ½ºÖÊϸ°û·¢ÉúËðÉË»òÕß¹¦Ð§Ê§³£µÄ¼²²¡¡£Æä¿É·ÖΪ¼±ÐÔÉñ¾ÍËÐÐÐÔ¼²²¡ºÍÂýÐÔÉñ¾ÍËÐÐÐÔ¼²²¡£¬Ç°ÕßÖ÷Òª°üÂÞÄÔȱѪ£¨Cerebral Ischemia, CI£©¡¢ÄÔËðÉË£¨Brain Injury, BI£©¡¢ñ²ðEpilepsy£©µÈ£»ºóÕß°üÂÞ°¢¶û´Äº£Ä¬Ö¢£¨Alzheimer's Disease£©¡¢ÅÁ½ðɲ¡£¨Parkinson's Disease£©¡¢ºàÍ¢¶ÙÎ赸֢£¨Huntington's Disease£©¡¢¼¡Î®ËõÐÔ²àË÷Ó²»¯Ö¢£¨Amyotrophic Lateral Sclerosis, ALS£©µÈ¡£
¼¡Î®Ëõ²àË÷Ó²»¯Ö¢£¨Amyotrophic Lateral Sclerosis, ALS£©£¬ÓÖÃû¡°½¥¶³Ö¢¡±£¬ÊÇÒ»ÀàÓÉ´óÄԺͼ¹ËèÖÐÔ˶¯Éñ¾ÔªËÀÍöÒýÆðµÄÈ«ÇòµÚÈý´óÉñ¾ÍËÐÐÐÔ¼²²¡£¬±»ÊÀ½çÎÀÉú×éÖ¯ÁÐΪÎå´ó¾øÖ¢Ö®Ò»¡£Ä¿Ç°ALSµÄ·¢²¡»úÖÆÈÔ²»Ã÷È·£¬´æÔÚ²îÒì¼Ù˵£¬·¢²¡»úÀíµÄÍÆ²âÖ÷ÒªÎ§ÈÆ»ùÒòÍ»±ä¡¢Çé¿öÎÛȾ¡¢ÖؽðÊôÖж¾¡¢²¡¶¾ÇÖȾµÈ¡£ÆäÖмÒ×åÐÔ»¼ÕßÔ¼Õ¼5%~10%£¬Ö÷ÒªÓÉ»ùÒòÍ»±äÔì³É¡£
½üÄêÀ´²»Í£ÓÐALS·¢²¡Ïà¹Ø»ùÒò±»·¢ÏÖ£¬Æù½ñ±¨µÀµÄÔ¼Óм¸Ê®ÖÖ£¬ÒÑ·¢ÏÖµ¼Ö¼Ò×åÐÔALSµÄÍ»±ä»ùÒò°üÂÞSOD1¡¢RNFºÍTARDBPµÈ¡£Õë¶ÔÕâЩALSµÄÈÈÃÅ»ùÒòÍ»±äλµã¼°Ò©ÎïÑо¿Í´µã£¬ogÊÓѶ¹ÙÍø×¢²áƽ̨»®·Ö¹¹½¨ÁËÒÔÏÂÄ£ÐÍÒÔÂú×ãALSÒ©ÎïÑз¢ÐèÇó¡£
| Ʒϵ±àºÅ | Ʒϵ¼ò³Æ | ¹¹½¨·½Ê½ | Ä£ÐÍÌØµã |
